Go to deals
Private Equity | Agriculture | Consumer & Retail

Zamira Australia has raised US$5.4 million to fund Companion Animal’s growth initiatives

Zamira Australia has completed a fundraising to support Companion Animal’s growth initiatives and further strengthen its balance sheet.

Zamira is an Australian animal health brand whose mission is to improve the health and well-being of animals across the world. The company is favorably positioned as a premium brand, with localized understanding and expertise – a trusted and strong Australian brand identity amongst its international competitors. The Companion Animal range is Zamira’s new line of Australian-made premium supplements for pets. Formulated by Australian vets using ethically sourced ingredients, ZamiPet helps support digestive and immune function, maintain vitality, joint health, cognitive function, skin, coat and nails, as well as helping support the reduction of stress, tension and anxiety in dogs.

Oaklins’ team in Australia acted as corporate advisor and lead manager to the raise and continues to support Zamira as they strive to become a leader in pet health and well-being, and a global leader in the supply of animal health products.

Funding, debt advisory & ECM

Talk to the deal team

 Justin  Lewis

Justin Lewis

Managing Director
Melbourne, Australia
Oaklins Henslow

Related deals

Ricotto has been acquired by Sitra Group
Private Equity | Logistics

Ricotto has been acquired by Sitra Group

Ricotto S.r.l. has joint Sitra Group, a Belgium-based and PE-backed international logistic and transportation group.

Learn more
M80 Partners has acquired Luminis
Private Equity | TMT

M80 Partners has acquired Luminis

Belgian private equity fund M80 has acquired a majority stake in Luminis. M80 offers to software and technology company Luminis the opportunity to further expand its strategy and market position internationally. Luminis becomes part of a platform that also includes XPLUS, a Belgian expert in enterprise IT architecture. M80 plans to make further selective acquisitions in Europe in the coming months with the aim of bringing together a portfolio of best-in-class digital transformation specialists.

Learn more
Spice Private Equity Ltd. has had a fairness opinion conducted on a public tender offer by GP Investments
Private Equity | Other Industries

Spice Private Equity Ltd. has had a fairness opinion conducted on a public tender offer by GP Investments

On 14 July 2022, GP Swiss Ltd., a subsidiary of GP Investments, published a public tender offer for all publicly held registered shares of Spice Private Equity Ltd. (Spice). The independent members of the Board of Directors of Spice have had a fairness opinion conducted on the financial adequacy of this public tender offer. The offer price for each Spice share was US$16.25 net in cash. Following a successful offer, GP Investment intends to delist the stock from the SIX Swiss Stock Exchange.

Learn more